Short Massages Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Dyslipidemia
- Sponsor
- Hillel Yaffe Medical Center
- Enrollment
- 120
- Locations
- 1
- Primary Endpoint
- Number of patients who achieve target goals
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
The objective of the study is to determine whether short text massages could be used successfully as a compliance aid and improve clinical outcomes in long term lipid lowering therapy.
Detailed Description
Indication: Patients discharged from the Intensive Cardiac Care Unit or the Internal Medicine Department following acute coronary syndrome (ACS) events such as unstable angina or acute myocardial infarction who will be prescribed a statin for the first time for preventing further coronary episodes. Drug(s) and Dose/Regimen: Regular or aggressive Simvastatin therapy (dose will be adjusted according to LDL and Total Cholesterol levels). Treatment period 6 months. Objectives: To determine whether using SMS technology can improve compliance and hence clinical outcomes in patients with long-term lipid lowering therapy. Primary outcome: number of patients who achieve target LDL goals. Secondary outcomes: reductions of total cholesterol, LDL, LDL/HDL and CRP; increase of HDL; Readmissions due to ACS. Study Background/Rationale/Purpose: Long-term lipid lowering therapy is the cornerstone of preventing recurrent cardiac events in patients that have experienced such episodes. Numerous studies have demonstrated the efficacy of statins in the treatment of hyperlipidemia and reduction of total mortality, vascular mortality and coronary adverse events1. One of the main concerns affecting the success of long-term chronic drug treatments is patients' compliance and adherence to the prescribed regimen. Till date there is no gold standard system that will assure complete patient compliance. It has been suggested to explore the possibility of using short messages service (SMS) technology to improve patients' compliance 2-18. Such technology may be effective in targeting this problem; however, no controlled trials have been conducted to validate this method in long-term lipid lowering treatments. Furthermore, Israel is one of the leading countries in terms of expansion of the mobile phone services market, making SMS a feasible and effective form of communication with patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients discharged from the Intensive Cardiac Care Unit or the Internal Medicine Department following ACS who will be prescribed a statin for the first time for preventing further coronary episodes.
- •Patients in the ages of 18-
- •Patients who own mobile phone and are familiar with SMS technology and are able to read Hebrew text.
Exclusion Criteria
- •Contra indication to study medication: active liver disease or elevated liver enzymes; hypersensitivity to Simvastatin; pregnancy and lactation.
- •Developed Myopathy/Rhabodmyalisis during study period.
- •Developed increase in transaminases greater than 3 times the upper limit of normal.
- •Current lipid lowering treatment (statins or other).
Outcomes
Primary Outcomes
Number of patients who achieve target goals
Time Frame: Every three months at one year period
Secondary Outcomes
- Total cholesterol, LDL, HDL, TG(Every three months at one year period)